Creative Biolabs Builds a Smarter Path to Complement Therapeutics Research

In the world of drug development, the leap from concept to clinic is often a long and winding road.

Creative Biolabs is quietly reshaping that journey—one assay, one chip, one insight at a time.

Their latest offerings are more than just tools, built with scientists in mind who are navigating the early stages of therapeutic discovery.

Creative Biolabs now offers a series of featured services that accelerate complementary therapeutic development.
The CH50 functional test kit is a hemolysis-based assay that quantifies the activity of the classical pathway of the complement system.

"This kit isn't just giving you data—it's giving you confidence,"

"We've seen consistent, reproducible results in the lab, so it's a good early-stage screening tool."

Author's summary: Creative Biolabs accelerates therapeutic development.

MarketersMEDIA Newsroom — 2025-10-27